Every state, kept current
The Rates plan
$29/mo7-day free trialThis page shows one representative rate per state for G0659. Full schedules include every locality, modifier, and age-band variant.
- Every code on all 51 published schedules
- Full-schedule CSV export and state network lists
- Email alerts when a state changes its rates
$29/mo after the trial. Cancel anytime.
Publishing states
23
Median % of Medicare
98.4%
Rate range
$46.60 - $85.13
G0659 rates in every publishing state
| State | Medicaid rate | % of Medicare | Prior auth | Vintage |
|---|---|---|---|---|
| California | $62.14 | 100% | -- | 2026 |
| District of Columbia | $49.71 | 80% | Not required | 2020 |
| Georgia | $61.16 | 98.4% | -- | 2026 |
| Iowa | $66.48 | 107% | -- | 2024 |
| Idaho | $53.69 | 86.4% | Not required | 2025 |
| Illinois | $46.60 | 75% | -- | 2016 |
| Indiana | $62.14 | 100% | -- | 2020 |
| Kentucky | $62.14 | 100% | -- | 2026 |
| Massachusetts | $54.80 | 88.2% | -- | 2024 |
| Minnesota | $62.14 | 100% | -- | 2020 |
| Missouri | $55.93 | -- | Not required | 2026 |
| Mississippi | $55.93 | 90% | -- | 2026 |
| Montana | $62.14 | 100% | -- | 2026 |
| North Dakota | $62.14 | 100% | Not required | 2026 |
| New Hampshire | $52.06 | 83.8% | Not required | 2026 |
| New Mexico | $62.14 | 100% | -- | 2025 |
| Oregon | $49.71* | 80% | -- | 2026 |
| Pennsylvania | $63.85 | -- | -- | 2017 |
| Texas | $85.13* | 137% | -- | 2021 |
| Virginia | $54.68 | 88% | -- | 2020 |
| Vermont | $60.59 | 97.5% | -- | 2026 |
| Wisconsin | $62.14 | 100% | -- | 2020 |
| West Virginia | $55.93 | 90% | -- | 2026 |
Published Medicaid fee-for-service schedule amounts, not a coverage or eligibility guarantee. Managed-care plan rates can differ. Where no prior-authorization flag is shown, the state does not publish one. Rows marked * are representative published variants or methodology-derived rates. "--" in the prior-auth column means the state publishes no PA flag.
Related physician codes
- 10004 - Needle biopsy without imaging, each added lesion
- 10005 - Needle biopsy with ultrasound guidance, first lesion
- 10006 - Needle biopsy with ultrasound guidance, each added lesion
- 10007 - Needle biopsy with fluoroscopic guidance, first lesion
- 10009 - Needle biopsy with CT guidance, first lesion
- 10011 - Needle biopsy with MRI guidance, first lesion
- 10012 - Needle biopsy with MRI guidance, each added lesion
- 10021 - Fine needle aspiration biopsy, first lesion, no imaging
All 136 codes from G0008 to G0659 or every physician code by number.
Frequently asked questions
How much does Medicaid pay for G0659?
23 state Medicaid programs publish a fee-for-service rate for G0659 (drug test(s), definitive, utilizing drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem), excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase), performed without method or drug-specific calibration, without matrix-matched quality control material, or without use of stable isotope or other universally recognized internal standard(s) for each drug, drug metabolite or drug class per specimen; qualitative or quantitative, all sources, includes specimen validity testing, per day, any number of drug classes), ranging from $46.60 in Illinois to $85.13 in Texas, with a median of 98.4% of the national Medicare amount. The full table on this page lists every publishing state's current rate.
Which state pays the most for G0659?
Texas publishes the highest Medicaid rate for G0659 at $85.13 (137% of the national Medicare amount). Illinois publishes the lowest at $46.60.
Does G0659 require prior authorization under Medicaid?
No publishing state flags G0659 with a prior-authorization indicator on its fee schedule. Absence of a flag means the state publishes none, not that PA is never required - confirm through the state's provider manual.